← Eichor
Condition: Severe Burns Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Burns

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults
Phase 2 · 1 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT06469970
Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury
Phase N/A · 1 location(s) · Tamas Vegh, MD · NCT07329595
Albumin and Prognosis of Severely Patients Burns
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04264065
Presepsin Diagnostic Performance in Severe Burn Sepsis
Phase N/A · 1 location(s) · Dohern Kym · NCT07060560
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Phase 4 · 1 location(s) · University of Tennessee · NCT07465432
Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns
Phase 3 · 10 location(s) · Nantes University Hospital · NCT06968559
SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma
Phase 1/Phase 2 · 7 location(s) · CHU de Quebec-Universite Laval · NCT02350205
Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06670248
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.